Photon Biosciences, LLC was founded in 2017 to develop and market entirely new classes of genetically expressible phosphorescent proteins that never photobleach and have luminocities that rival GFP.
Originally formed as a Washington State University start-up, Photon Biosciences, LLC has received Phase I funding from the National Institutes of Health SBIR program (NIGMS SBIR) and a GAP grant from the Washington Research Foundation to develop our core technologies and commercialize a variety of product lines for the biomedical research community and biotechnology.
Our core technology is a new ultrasensitive detection platform that combines bioengineered proteins with a unique in vivo biomineralization process that results in a number of different genetically expressible luminescent bionanoparticles that are non-bleaching and non-blinking with luminescence intensities that rivals and surpasses many fluorescent organic molecules. The excitation and emission wavelengths of these expressible bionanoparticles can be tuned with the composition of the mineralization process and span much of the visible and near infrared regions of the electromagnetic spectrum. Because of its unique photophysical properties, RECAL has been developed into new ultrasensitive probes for biomolecular research, detection technologies, and cellular imaging.
Dr. Brozik is a co-Founder of Photon Biosciences and Distinguished Professor of Chemistry at Washington State University. Dr. Brozik has 28 years of experience as an optical spectroscopist including work with inorganic materials, non-linear phenomenon, molecular spectroscopy, single molecule spectroscopy, molecular biophysics, and instrument development.
Dr. Kang is a co-Founder of Photon Bioscience and Professor of Chemistry and Bioengineering at WSU. Dr. Kang is a leading expert on metal binding proteins with 38 years of experience as a biophysicist, protein engineer, and structural biochemist.
Chandima Bandara is the CEO of Photon Biosciences. Prior to joining Photon Biosciences, he worked in the Biotechnology industry in both research & development and marketing & sales where he was involved in innovation-driven rapid business growth in medium-scale biotechnology companies.
Dr. Kim is the Chief Protein Engineer for Photon Biosciences in charge of designing new luminescent proteins of varying sizes, colors, and luminosity. Dr. Kim has 15 years experience as a protein engineer and molecular biologist.
Dr. Dixon is a senior research scientist at Photon Biosciences and leads the development of small molecule fluorophores. He specializes in luminescence spectroscopy, synthetic organic chemistry, and biological imaging.
Dr. Lewis is a lead scientist in charge of protein chemistry and biophysical characterization. He has a background in biophysical chemistry, structural biology, and microbiology.
Dr. Borders is a senior scientist at Photon Biosciences in charge of the research and development of the RECAL product lines. He is a PhD Chemist specializing in luminescence spectroscopy, molecular imaging technology, single molecule spectroscopy, biophysical chemistry, and inorganic chemistry.